Colgate-Palmolive Shares Approach Critical Earnings Test Amid Steep Decline

Colgate-Palmolive shares have descended to their lowest point in fifty-two weeks as the company prepares to release its third-quarter 2025 financial results. The stock currently trades at $75.73 after declining 1.8% in the latest session, bringing its weekly loss to 5.2% and its monthly decrease to 4.6%. Year-over-year, the equity has shed nearly 19% of its value, placing significant pressure on tomorrow's earnings announcement to reverse the negative momentum.

The consumer goods giant continues to face substantial selling pressure across markets. With Thursday's drop to $75.73, the stock established a new annual low, reducing the company's market capitalization to $61.4 billion. Technical indicators uniformly point to continued downward movement, raising questions about whether the upcoming quarterly report can potentially alter this trajectory.

Analyst Expectations Set the Stage

Market experts anticipate Colgate-Palmolive will report earnings of $0.91 per share on revenue of $5.17 billion when it announces results at 8:30 AM ET tomorrow. This projected profit would represent a 2.2% contraction compared to the same quarter last year, though revenue is expected to show modest growth of approximately 2%.

The critical question remains whether these figures will be sufficient to halt the persistent decline in shareholder value.

Should investors sell immediately? Or is it worth buying Colgate-Palmolive?

Mixed Sentiment Among Research Firms

Despite the significant price deterioration, analyst consensus maintains a cautiously optimistic "Moderate Buy" rating. Among the fourteen firms covering the stock, eight recommend purchasing shares, five suggest holding positions, and only one advises selling. The average price target stands at $91.50, implying potential upside of nearly 21% from current levels.

This generally positive outlook comes with an important caveat: several brokerage houses have recently revised their projections downward in response to mounting challenges.

Key Financial Metrics:
* Current trading price near 52-week low: $75.73
* Projected Q3 earnings per share: $0.91
* Estimated Q3 revenue: $5.17 billion
* Analyst consensus rating: Moderate Buy
* Mean price target: $91.50

Dividend Stability Provides Some Comfort

Colgate-Palmolive continues its quarterly dividend distribution of $0.52 per share, payable on November 14. However, investors increasingly question whether the company can sustain these payouts amid ongoing operational pressures. Tomorrow's earnings release will likely determine whether the stock begins recovery or extends its downward trajectory further into negative territory.